• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Fc 受体在抗菌保护中的作用。

Fc Receptors in Antimicrobial Protection.

机构信息

Department of Microbiology & Immunology, School of Medicine, Emory University, 1510 Clifton Road, Atlanta, GA, USA.

出版信息

Curr Top Microbiol Immunol. 2019;423:119-150. doi: 10.1007/82_2019_154.

DOI:10.1007/82_2019_154
PMID:30790076
Abstract

Antibodies are the key effector molecules of the humoral immune system providing long-term protective immunity against a wide range of pathogens and regulating immune responses. Traditionally, antibody-mediated protection against microbes was thought to be mainly a result of neutralizing Fab-antigen interaction; however, an increasing number of studies show the importance of proper FcR engagement for the protective capacity of antimicrobial antibodies. In this chapter, we review FcR-mediated effector functions contributing to antimicrobial protection in a direct and indirect manner. Furthermore, we highlight recent findings about the important role of Fc-FcR interactions for antimicrobial protection in vivo and provide examples demonstrating the crucial role of proper FcR engagement for antibody-mediated protection against viruses, bacteria, fungi, and parasites.

摘要

抗体是体液免疫系统的关键效应分子,为机体提供针对广泛病原体的长期保护免疫,并调节免疫反应。传统上,抗体介导的针对微生物的保护作用被认为主要是由于中和 Fab 抗体-抗原相互作用的结果;然而,越来越多的研究表明,适当的 FcR 结合对于抗菌抗体的保护能力很重要。在本章中,我们综述了 FcR 介导的效应功能,这些功能以直接和间接的方式促进了抗菌保护。此外,我们强调了最近关于 Fc-FcR 相互作用在体内对抗菌保护的重要作用的发现,并提供了一些示例,这些示例证明了适当的 FcR 结合对于抗体介导的针对病毒、细菌、真菌和寄生虫的保护作用至关重要。

相似文献

1
Fc Receptors in Antimicrobial Protection.Fc 受体在抗菌保护中的作用。
Curr Top Microbiol Immunol. 2019;423:119-150. doi: 10.1007/82_2019_154.
2
Antibody-Fc receptor interactions in protection against intracellular pathogens.抗体-Fc 受体相互作用在预防细胞内病原体中的作用。
Eur J Immunol. 2011 Apr;41(4):889-97. doi: 10.1002/eji.201041340. Epub 2011 Mar 17.
3
Fc receptor regulation of protective immunity against Chlamydia trachomatis.Fc受体对沙眼衣原体保护性免疫的调节作用
Immunology. 2002 Feb;105(2):213-21. doi: 10.1046/j.0019-2805.2001.01354.x.
4
Analyzing antibody-Fc-receptor interactions.分析抗体-Fc受体相互作用。
Methods Mol Biol. 2008;415:151-62. doi: 10.1007/978-1-59745-570-1_9.
5
Broadly neutralizing anti-influenza antibodies require Fc receptor engagement for in vivo protection.广泛中和性抗流感抗体在体内发挥保护作用需要Fc受体参与。
J Clin Invest. 2016 Feb;126(2):605-10. doi: 10.1172/JCI84428. Epub 2016 Jan 5.
6
Antigen-specific antibody Fc glycosylation enhances humoral immunity via the recruitment of complement.抗原特异性抗体 Fc 糖基化通过募集补体增强体液免疫。
Sci Immunol. 2018 Aug 17;3(26). doi: 10.1126/sciimmunol.aat7796.
7
Fc receptor-mediated antibody regulation of T cell immunity against intracellular pathogens.Fc受体介导的抗体对针对细胞内病原体的T细胞免疫的调节作用。
J Infect Dis. 2003 Aug 15;188(4):617-24. doi: 10.1086/377134. Epub 2003 Jul 29.
8
Understanding Fc function for rational vaccine design against pathogens.理解 Fc 功能,有助于针对病原体进行合理的疫苗设计。
mBio. 2024 Jan 16;15(1):e0303623. doi: 10.1128/mbio.03036-23. Epub 2023 Dec 19.
9
Accelerated internalization and detoxification of endotoxin by anti-lipopolysaccharide antibody is an Fc receptor--mediated process.抗脂多糖抗体对内毒素的加速内化和解毒是一个由Fc受体介导的过程。
Surgery. 2001 Aug;130(2):192-7. doi: 10.1067/msy.2001.115825.
10
Antibody regulation of Tcell immunity: implications for vaccine strategies against intracellular pathogens.抗体对T细胞免疫的调节:对针对细胞内病原体的疫苗策略的启示
Expert Rev Vaccines. 2004 Feb;3(1):23-34. doi: 10.1586/14760584.3.1.23.

引用本文的文献

1
Novel Bivalent mRNA-LNP Vaccine for Highly Effective Protection against Pneumonic Plague.用于高效预防肺鼠疫的新型二价mRNA-LNP疫苗。
Adv Sci (Weinh). 2025 Jul;12(26):e2501286. doi: 10.1002/advs.202501286. Epub 2025 Apr 25.
2
Immunoglobulin Replacement Therapy: Insights into Multiple Myeloma Management.免疫球蛋白替代疗法:对多发性骨髓瘤管理的见解
Cancers (Basel). 2024 Sep 18;16(18):3190. doi: 10.3390/cancers16183190.
3
Immune microenvironment of human papillomavirus-positive head and neck squamous cell carcinoma.人乳头瘤病毒阳性头颈部鳞状细胞癌的免疫微环境。
Sci Prog. 2024 Jan-Mar;107(1):368504241237888. doi: 10.1177/00368504241237888.
4
Development of an RBD-Fc fusion vaccine for COVID-19.一种用于新型冠状病毒肺炎的受体结合域-融合蛋白(RBD-Fc)融合疫苗的研发。
Vaccine X. 2024 Jan 21;16:100444. doi: 10.1016/j.jvacx.2024.100444. eCollection 2024 Jan.
5
The advances of adjuvants in mRNA vaccines.mRNA疫苗中佐剂的进展。
NPJ Vaccines. 2023 Oct 26;8(1):162. doi: 10.1038/s41541-023-00760-5.
6
The Tumor-Specific Immune Landscape in HPV+ Head and Neck Cancer.HPV+ 头颈部癌的肿瘤特异性免疫景观。
Viruses. 2023 May 31;15(6):1296. doi: 10.3390/v15061296.
7
Elicitation of potent neutralizing antibodies in obese mice by ISA 51-adjuvanted SARS-CoV-2 spike RBD-Fc vaccine.ISA 51 佐剂的 SARS-CoV-2 刺突 RBD-Fc 疫苗在肥胖小鼠中引发强烈的中和抗体反应。
Appl Microbiol Biotechnol. 2023 May;107(9):2983-2995. doi: 10.1007/s00253-023-12490-8. Epub 2023 Mar 29.
8
B cell class switch recombination is regulated by DYRK1A through MSH6 phosphorylation.B 细胞类别转换重组受 DYRK1A 通过 MSH6 磷酸化调节。
Nat Commun. 2023 Mar 16;14(1):1462. doi: 10.1038/s41467-023-37205-5.
9
Systems serology-based comparison of antibody effector functions induced by adjuvanted vaccines to guide vaccine design.基于系统血清学比较佐剂疫苗诱导的抗体效应功能以指导疫苗设计
NPJ Vaccines. 2023 Mar 8;8(1):34. doi: 10.1038/s41541-023-00613-1.
10
A single-dose F1-based mRNA-LNP vaccine provides protection against the lethal plague bacterium.一针剂基于 F1 的 mRNA-LNP 疫苗为致命鼠疫菌提供保护。
Sci Adv. 2023 Mar 10;9(10):eadg1036. doi: 10.1126/sciadv.adg1036. Epub 2023 Mar 8.